For Investors

Press Releases

Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be considered

03/01/24

The decision was communicated through CMS’ bi-annual Healthcare Common Procedure Coding System (“HCPCS”) coding memorandum released yesterday; payment amount determination for ReWalk Personal Exoskeletons will continue to be on a case-by-case basis until such determination is finalized, likely

Read More
Read More

Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results

02/27/24

Highest quarterly and annual revenue in the history of Lifeward Commercial and operational integration complete; synergies expected to yield $3 million in annual net savings MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™),

Read More
Read More

Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024

02/20/24

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the

Read More
Read More

ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward

01/29/24

Lifeward brand reflects the Company’s commitment to pioneering innovative technology to empower the pursuit of life’s ambitions in the face of physical limitation or disability The complete rebrand includes new name, stock ticker, logo, website launch, and corporate messaging MARLBOROUGH, Mass.

Read More
Read More

ReWalk Robotics Expands Direct Sales Coverage to Canada

01/12/24

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel , Jan. 12, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. ( Nasdaq: RWLK ) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with

Read More
Read More

ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17

01/11/24

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Jan. 11, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced that Larry Jasinski , Chief Executive Officer, and Mike Lawless , Chief Financial Officer, will provide an overview presentation and

Read More
Read More

First ReWalk Personal Exoskeleton Claim Paid by Medicare

01/05/24

ReWalk Personal Exoskeleton covered as a medically necessary device for an eligible Medicare beneficiary with spinal cord injury MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel , Jan. 05, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), a leading provider of

Read More
Read More

ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities

01/04/24

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel , Jan. 04, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. ( Nasdaq: RWLK ) (“ReWalk” or the “Company”), today issued an open letter from Larry Jasinski , Chief Executive Officer, to shareholders detailing transformational achievements in 2023

Read More
Read More

ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting

11/30/23

ReWalk supports “gap-filling” pricing method proposed by CMS with use of up-to-date pricing information. MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel , Nov. 30, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics , Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading provider of innovative

Read More
Read More

ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype

11/28/23

R&D Grant from the Israeli Technology Innovation Consortium Enabled the Successful Demonstration of a Working Prototype MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel , Nov. 28, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics , Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading provider

Read More
Read More

ReWalk Robotics Reports Third Quarter 2023 Financial Results

11/14/23

Record Quarterly Revenue of $4.4 Million Successful Completion of AlterG Acquisition and Significant Progress of Integration Major Advancement in Efforts to Attain Medicare Payment Coverage of Exoskeletons MARLBOROUGH, Mass. , BERLIN and YOKNEAM ILLIT, Israel , Nov.

Read More
Read More

New Bill Facilitates Veteran Access to Powered Exoskeletons

11/10/23

Veterans STAND Act mandates regular evaluations of paralyzed Veterans and proactively identifies clinically-eligible Veterans for expedited procurement of personal exoskeletons MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Nov. 10, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd.

Read More
Read More
Displaying 25 - 36 of 299